Search research articles
Contact Us
Filters
Showing results (1-10 of 24) with videos related to
Page
of 3
Sort By:
British Heart Journal
|
June 1, 1977
Massive digoxin ingestion. Report of a case and review of currently available therapies
W F Bremner, J L Third, T D Lawrie
Clinical Chemistry
|
December 1, 1975
Diagnosis of type III hyperlipoproteinemia by chromatography of plasma lipoproteins on columns containing agarose
J Shepherd, C J Packard, F J Dryburgh, et al.
Atherosclerosis
|
March 1, 1978
Regulation of cholesterol synthesis in the hyperlipoproteinaemias. Polymorphonuclear leucocyte abnormality specific to familial type II hypercholesterolaemia
W F Bremner, J L Third, B Clark, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
February 1, 1978
Effect of clofibrate on the composition of very low and low density lipoprotein subfractions in type III hyperlipoproteinaemia
D Ballantyne, F C Ballantyne, P Stromberg, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
August 15, 1977
The composition of low (LDL) and very low (VLDL) density lipoprotein subfractions in type III hyperlipoproteinaemia: comparison with normal subjects
P Stromber, D Ballantyne, F C Ballantyne, et al.
Metabolism: Clinical and Experimental
|
February 1, 1984
Primary and familial hypoalphalipoproteinemia
J L Third, J Montag, M Flynn, et al.
American Journal of Human Genetics
|
March 1, 1986
A major gene for primary hypoalphalipoproteinemia
I B Borecki, D C Rao, J L Third, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
March 15, 1977
Electrophoretic mobility in agarose of very low density lipoprotein subfractions in type III hyperlipoproteinaemia
F C Ballantyne, D K Bedford, D Ballantyne, et al.
Atherosclerosis
|
August 1, 1979
The effects of cholestyramine on high density lipoprotein metabolism
J Shepherd, C J Packard, H G Morgan, et al.
Journal of Lipid Research
|
November 1, 1982
Studies of familial type III hyperlipoproteinemia using as a genetic marker the apoE phenotype E2/2
J L Breslow, V I Zannis, T R SanGiacomo, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 24) with videos related to
Sort By:
Page
of 3
British Heart Journal
|
June 1, 1977
Massive digoxin ingestion. Report of a case and review of currently available therapies
W F Bremner, J L Third, T D Lawrie
Clinical Chemistry
|
December 1, 1975
Diagnosis of type III hyperlipoproteinemia by chromatography of plasma lipoproteins on columns containing agarose
J Shepherd, C J Packard, F J Dryburgh, et al.
Atherosclerosis
|
March 1, 1978
Regulation of cholesterol synthesis in the hyperlipoproteinaemias. Polymorphonuclear leucocyte abnormality specific to familial type II hypercholesterolaemia
W F Bremner, J L Third, B Clark, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
February 1, 1978
Effect of clofibrate on the composition of very low and low density lipoprotein subfractions in type III hyperlipoproteinaemia
D Ballantyne, F C Ballantyne, P Stromberg, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
August 15, 1977
The composition of low (LDL) and very low (VLDL) density lipoprotein subfractions in type III hyperlipoproteinaemia: comparison with normal subjects
P Stromber, D Ballantyne, F C Ballantyne, et al.
Metabolism: Clinical and Experimental
|
February 1, 1984
Primary and familial hypoalphalipoproteinemia
J L Third, J Montag, M Flynn, et al.
American Journal of Human Genetics
|
March 1, 1986
A major gene for primary hypoalphalipoproteinemia
I B Borecki, D C Rao, J L Third, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
March 15, 1977
Electrophoretic mobility in agarose of very low density lipoprotein subfractions in type III hyperlipoproteinaemia
F C Ballantyne, D K Bedford, D Ballantyne, et al.
Atherosclerosis
|
August 1, 1979
The effects of cholestyramine on high density lipoprotein metabolism
J Shepherd, C J Packard, H G Morgan, et al.
Journal of Lipid Research
|
November 1, 1982
Studies of familial type III hyperlipoproteinemia using as a genetic marker the apoE phenotype E2/2
J L Breslow, V I Zannis, T R SanGiacomo, et al.
Page
of 3